Found: 13
Select item for more details and to access through your institution.
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 465, doi. 10.1007/s40120-024-00586-w
- By:
- Publication type:
- Article
Monitoring of Perioperative Microcirculation Dysfunction by Near-Infrared Spectroscopy for Neurological Deterioration and Prognosis of Aneurysmal Subarachnoid Hemorrhage: An Observational, Longitudinal Cohort Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 475, doi. 10.1007/s40120-024-00585-x
- By:
- Publication type:
- Article
Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 437, doi. 10.1007/s40120-024-00583-z
- By:
- Publication type:
- Article
Understanding the Symptoms and Impacts Experienced by People with Relapsing–Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 449, doi. 10.1007/s40120-024-00584-y
- By:
- Publication type:
- Article
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 415, doi. 10.1007/s40120-024-00582-0
- By:
- Publication type:
- Article
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 323, doi. 10.1007/s40120-023-00574-6
- By:
- Publication type:
- Article
Conversion to Brivaracetam Monotherapy in Clinical Practice: A Retrospective Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 389, doi. 10.1007/s40120-024-00580-2
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 355, doi. 10.1007/s40120-024-00578-w
- By:
- Publication type:
- Article
Textbook Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage Following Endovascular Treatment.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 373, doi. 10.1007/s40120-024-00577-x
- By:
- Publication type:
- Article
Acute Treatment of Migraine: Expert Consensus Statements from the United Arab Emirates (UAE).
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 257, doi. 10.1007/s40120-023-00576-4
- By:
- Publication type:
- Article
Clinical and Polysomnographic Characteristics of Adult Patients with Suspected Obstructive Sleep Apnea from Different Sleep Clinics at a Single Tertiary Center.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 399, doi. 10.1007/s40120-024-00581-1
- By:
- Publication type:
- Article
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 339, doi. 10.1007/s40120-023-00575-5
- By:
- Publication type:
- Article
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 283, doi. 10.1007/s40120-023-00565-7
- By:
- Publication type:
- Article